HK1178446A1 - Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives - Google Patents

Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives

Info

Publication number: HK1178446A1
Authority: HK; Hong Kong
Prior art keywords: nonviscous; prostaglandin; preservatives; delivery system; based solution
Prior art date: 2010-06-29

Application number

HK13105429.5A

Other languages

English (en)

Chinese (zh)

Inventor

法布裏斯．梅爾切爾

Original Assignee

泰阿實驗室

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-06-29

Filing date

2013-05-06

Publication date

2013-09-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43064334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1178446(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-05-06 Application filed by 泰阿實驗室 filed Critical 泰阿實驗室

2013-09-13 Publication of HK1178446A1 publication Critical patent/HK1178446A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

HK13105429.5A 2010-06-29 2013-05-06 Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives HK1178446A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US35969910P	2010-06-29	2010-06-29
FR1055236A FR2961694B1 (fr)	2010-06-29	2010-06-29	Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
PCT/EP2011/060848 WO2012001009A1 (fr)	2010-06-29	2011-06-28	Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur

Publications (1)

Publication Number	Publication Date
HK1178446A1 true HK1178446A1 (en)	2013-09-13

Family

ID=43064334

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
HK13105429.5A HK1178446A1 (en)	2010-06-29	2013-05-06	Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives
HK15102052.4A HK1201464A1 (en)	2010-06-29	2015-02-27	Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
HK15102052.4A HK1201464A1 (en)	2010-06-29	2015-02-27	Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives

Country Status (27)

Country	Link
US (2)	US20110319487A1 (xx)
EP (1)	EP2588078B1 (xx)
JP (2)	JP5657789B2 (xx)
KR (1)	KR101809713B1 (xx)
CN (2)	CN102958509B (xx)
AU (1)	AU2011273549B2 (xx)
BR (1)	BR112012033435B1 (xx)
CA (1)	CA2802816C (xx)
CL (1)	CL2012003684A1 (xx)
CO (1)	CO6660508A2 (xx)
DK (1)	DK2588078T3 (xx)
EA (1)	EA025026B1 (xx)
ES (1)	ES2486793T3 (xx)
FR (1)	FR2961694B1 (xx)
HK (2)	HK1178446A1 (xx)
HR (1)	HRP20140631T1 (xx)
MA (1)	MA34324B1 (xx)
MX (1)	MX2012014503A (xx)
PL (1)	PL2588078T3 (xx)
PT (1)	PT2588078E (xx)
RS (1)	RS53417B (xx)
SG (1)	SG186361A1 (xx)
SI (1)	SI2588078T1 (xx)
SM (1)	SMT201400098B (xx)
TN (1)	TN2012000588A1 (xx)
UA (1)	UA107718C2 (xx)
WO (1)	WO2012001009A1 (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2553827T3 (es)	2009-05-01	2015-12-14	Aerie Pharmaceuticals, Inc.	Inhibidores de mecanismo doble para el tratamiento de enfermedad
FR2961694B1 (fr) *	2010-06-29	2013-01-25	Thea Lab	Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
US9278132B2 (en)	2012-02-13	2016-03-08	Bausch & Lomb Incorporated	Ophthalmic pharmaceutical compositions and methods of making and using same
US10113033B2 (en)	2013-03-08	2018-10-30	Polyactiva Pty Ltd	Polymer conjugate for delivery of a bioactive agent
KR102210895B1 (ko) *	2013-03-08	2021-02-02	폴리액티바 피티와이 리미티드	생리활성 물질의 전달을 위한 폴리머 결합체
CN104288092A (zh) *	2013-07-16	2015-01-21	广东东阳光药业有限公司	拉坦前列素滴眼剂
US9115109B2 (en) *	2013-08-15	2015-08-25	Chirogate International Inc.	Processes and intermediates for the preparations of isomer free prostaglandins
EP3057575B1 (en)	2013-10-15	2021-09-08	Pharmathen S.A.	Preservative free pharmaceutical compositions for ophthalmic administration
GR1008330B (el) *	2013-10-17	2014-10-20	"Φαρματεν Α.Β.Ε.Ε.",	Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση εχoν βελτιωμενες φυσικες ιδιοτητες και ογκο σταγονας
GR1008483B (el) *	2013-12-23	2015-05-12	Rafarm Α.Ε.Β.Ε.,	Οφθαλμικη φαρμακευτικη συνθεση και μεθοδος για την παρασκευη αυτης
CN105012231A (zh) *	2014-04-30	2015-11-04	四川科伦药物研究院有限公司	一种包含PGF2α衍生物的稳定性良好的眼用制剂及其制备方法
ES2584534B1 (es) *	2015-03-27	2017-03-13	Retinset, S.L.	Formulación tópica oftálmica de bosentan
PL3103439T3 (pl) *	2015-06-09	2019-12-31	Medproject Pharma-Entwicklungs- Und Vertriebsgesellschaft Mbh	Zdolny do tworzenia kropli oftalmiczny żel bimatoprostu
GR1009040B (el)	2016-04-19	2017-05-19	Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων	Φαρμακευτικο οφθαλμικο σκευασμα ελευθερο συντηρητικου
WO2018033854A1 (en) *	2016-08-15	2018-02-22	Santen Pharmaceutical Co., Ltd.	Ophthalmic composition and a method for treating ocular hypertension and glaucoma
US11389441B2 (en)	2016-08-31	2022-07-19	Aerie Pharmaceuticals, Inc.	Ophthalmic compositions
IT201600103956A1 (it) *	2016-10-17	2018-04-17	Omikron Italia S R L	Formulazione oftalmica comprendente citicolina veicolata da liposomi per il trattamento del glaucoma
KR101770324B1 (ko) *	2016-11-09	2017-08-22	주식회사태준제약	안압 강하용 점안 조성물
US11207417B2 (en)	2017-03-14	2021-12-28	Polyactiva Pty Ltd	Drug-polymer conjugate
US11696955B2 (en)	2017-03-14	2023-07-11	Polyactiva Pty Ltd	Drug-polymer conjugate
CA3054084A1 (en)	2017-03-14	2018-09-20	Polyactiva Pty Ltd	Biodegradable drug-polymer conjugate
AU2018243687C1 (en)	2017-03-31	2020-12-24	Alcon Inc.	Aryl cyclopropyl-amino-isoquinolinyl amide compounds
WO2018236158A1 (ko) *	2017-06-22	2018-12-27	연성정밀화학(주)	녹내장 치료용 점안 조성물
EP3593788B1 (en) *	2018-07-12	2020-10-28	Nicox S.A.	Ophthalmic compositions containing a nitric oxide releasing prostamide
CA3145888A1 (en) *	2018-07-31	2020-02-06	Isilay KAVADARLI	Ophthalmic formulations and uses thereof
EP3849555A4 (en)	2018-09-14	2022-05-04	Aerie Pharmaceuticals, Inc.	Aryl cyclopropyl-amino-isoquinolinyl amide compounds
CN110711175A (zh) *	2019-11-12	2020-01-21	南京华盖制药有限公司	一种他氟前列素滴眼剂及其制备方法
US11857538B2 (en) *	2022-01-14	2024-01-02	Somerset Therapeutics, Llc	Stable pilocarpine formulations with modified buffer characteristics and related methods
US11857539B2 (en)	2022-02-09	2024-01-02	Somerset Therapeutics, Llc	Gel ophthalmic formulations of pilocarpine and brimonidine compounds and related methods
CN115671037A (zh) *	2022-11-21	2023-02-03	山东诺明康药物研究院有限公司	一种溴莫尼定噻吗洛尔pH敏感型原位凝胶及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US10021A (en) *		1853-09-13		Screw-eastemtito- for boots and shoes
IL80298A (en)	1986-10-14	1993-01-31	Res & Dev Co Ltd	Eye drops
US5631287A (en)	1994-12-22	1997-05-20	Alcon Laboratories, Inc.	Storage-stable prostaglandin compositions
US6646001B2 (en) *	1997-12-19	2003-11-11	Alcon Manufacturing, Ltd.	Use of non-steroidal anti-inflammatory agents in combination with prostaglandin FP receptor agonists to treat glaucoma and ocular hypertension
NZ507026A (en) *	1998-04-02	2003-09-26	Novartis Ag	Method for stabilizing pharmaceutical compositions by special use of an antioxidant
AR035541A1 (es) *	2000-11-13	2004-06-16	Pharmacia Ab	Un metodo de tratamiento para pacientes que sufren de glaucoma severo o necesitan una reduccion de la presion intraocular (pio) y el uso de una combinacion de agentes reductores de la pio
US7074827B2 (en) *	2002-10-24	2006-07-11	Sucampo Ag (Usa) Inc.	Method for treating ocular hypertension and glaucoma
FR2918891B1 (fr) *	2007-07-20	2009-09-25	Thea Sa Lab	Solution ophtalmique a base de prostaglandines sans conservateur
MX2010003364A (es) *	2007-10-08	2010-07-06	Lux Biosciences Inc	Composiciones oftalmicas que comprenden inhibidores de calcineurina o inhibidores de mtor.
BRPI0818459A2 (pt) *	2007-10-16	2015-04-14	Sun Pharma Advanced Res Co Ltd	Composição farmacêutica adequada para uso oftálmico.
EP2127638A1 (en) *	2008-05-30	2009-12-02	Santen Pharmaceutical Co., Ltd	Method and composition for treating ocular hypertension and glaucoma
FR2961694B1 (fr)	2010-06-29	2013-01-25	Thea Lab	Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur

2010
- 2010-06-29 FR FR1055236A patent/FR2961694B1/fr active Active
2011
- 2011-06-28 ES ES11727707.9T patent/ES2486793T3/es active Active
- 2011-06-28 UA UAA201301063A patent/UA107718C2/ru unknown
- 2011-06-28 US US13/170,716 patent/US20110319487A1/en not_active Abandoned
- 2011-06-28 KR KR1020127033996A patent/KR101809713B1/ko active Active
- 2011-06-28 BR BR112012033435-2A patent/BR112012033435B1/pt active IP Right Grant
- 2011-06-28 MA MA35472A patent/MA34324B1/fr unknown
- 2011-06-28 CN CN201180032001.9A patent/CN102958509B/zh active Active
- 2011-06-28 EP EP11727707.9A patent/EP2588078B1/fr active Active
- 2011-06-28 RS RS20140353A patent/RS53417B/en unknown
- 2011-06-28 DK DK11727707.9T patent/DK2588078T3/da active
- 2011-06-28 JP JP2013517254A patent/JP5657789B2/ja active Active
- 2011-06-28 PT PT117277079T patent/PT2588078E/pt unknown
- 2011-06-28 SI SI201130234T patent/SI2588078T1/sl unknown
- 2011-06-28 EA EA201291307A patent/EA025026B1/ru not_active IP Right Cessation
- 2011-06-28 SG SG2012092284A patent/SG186361A1/en unknown
- 2011-06-28 MX MX2012014503A patent/MX2012014503A/es active IP Right Grant
- 2011-06-28 CN CN201410538280.1A patent/CN104274396B/zh active Active
- 2011-06-28 PL PL11727707T patent/PL2588078T3/pl unknown
- 2011-06-28 AU AU2011273549A patent/AU2011273549B2/en active Active
- 2011-06-28 CA CA2802816A patent/CA2802816C/fr active Active
- 2011-06-28 WO PCT/EP2011/060848 patent/WO2012001009A1/fr active Application Filing
2012
- 2012-08-27 US US13/595,165 patent/US8637054B2/en active Active
- 2012-12-12 TN TNP2012000588A patent/TN2012000588A1/fr unknown
- 2012-12-26 CL CL2012003684A patent/CL2012003684A1/es unknown
- 2012-12-27 CO CO12234226A patent/CO6660508A2/es not_active Application Discontinuation
2013
- 2013-05-06 HK HK13105429.5A patent/HK1178446A1/xx unknown
2014
- 2014-07-02 HR HRP20140631AT patent/HRP20140631T1/hr unknown
- 2014-07-23 SM SM201400098T patent/SMT201400098B/xx unknown
- 2014-09-19 JP JP2014191849A patent/JP5877885B2/ja active Active
2015
- 2015-02-27 HK HK15102052.4A patent/HK1201464A1/xx unknown

Also Published As

Publication number	Publication date
SMT201400098B (it)	2014-09-08
HK1201464A1 (en)	2015-09-04
JP2013532159A (ja)	2013-08-15
KR20130112728A (ko)	2013-10-14
TN2012000588A1 (fr)	2014-04-01
US20120322871A1 (en)	2012-12-20
MA34324B1 (fr)	2013-06-01
CN104274396A (zh)	2015-01-14
EP2588078A1 (fr)	2013-05-08
EA201291307A1 (ru)	2013-05-30
CA2802816A1 (fr)	2012-01-05
JP2015038099A (ja)	2015-02-26
JP5877885B2 (ja)	2016-03-08
JP5657789B2 (ja)	2015-01-21
CA2802816C (fr)	2015-05-12
MX2012014503A (es)	2013-01-29
EA025026B1 (ru)	2016-11-30
DK2588078T3 (da)	2014-08-18
EP2588078B1 (fr)	2014-05-14
PL2588078T3 (pl)	2014-09-30
PT2588078E (pt)	2014-07-16
CL2012003684A1 (es)	2013-03-08
UA107718C2 (en)	2015-02-10
SG186361A1 (en)	2013-01-30
CN104274396B (zh)	2017-07-04
BR112012033435A2 (pt)	2016-11-22
SI2588078T1 (sl)	2014-09-30
US8637054B2 (en)	2014-01-28
WO2012001009A1 (fr)	2012-01-05
AU2011273549B2 (en)	2013-06-27
RS53417B (en)	2014-12-31
HRP20140631T1 (hr)	2014-09-26
CO6660508A2 (es)	2013-04-30
CN102958509A (zh)	2013-03-06
CN102958509B (zh)	2015-01-21
KR101809713B1 (ko)	2017-12-15
BR112012033435B1 (pt)	2022-03-29
ES2486793T3 (es)	2014-08-19
US20110319487A1 (en)	2011-12-29
AU2011273549A1 (en)	2013-01-10
FR2961694A1 (fr)	2011-12-30
FR2961694B1 (fr)	2013-01-25

Publication	Publication Date	Title
HK1201464A1 (en)	2015-09-04	Polymeric delivery system for a nonviscous prostaglandin-based solution without preservatives
HK1218519A1 (zh)	2017-02-24	透析系統
RS58959B1 (sr)	2019-08-30	Sistem za isporučivanje pritiska
PL2793560T3 (pl)	2018-12-31	Złącze i kubek udojowy
EP2537380A4 (en)	2013-08-14	SYNCHRONIZATION IN A COMMUNICATION SYSTEM
GB2484327B (en)	2015-05-13	A connector system
HK1180565A1 (zh)	2013-10-25	液體輸送系統
ZA201208271B (en)	2014-01-29	A liquid delivery system
GB201020490D0 (en)	2011-01-19	Pump system
GB201011496D0 (en)	2010-08-25	A connector
GB201004553D0 (en)	2010-05-05	Barrier for a barrier connector
HK1208046A1 (en)	2016-02-19	A novel drug delivery system based on jcv-vlp jcv-
GB201219619D0 (en)	2012-12-12	A construction system
GB201002963D0 (en)	2010-04-07	A communication system
GB201014891D0 (en)	2010-10-20	A packaging system
GB201120783D0 (en)	2012-01-11	A communication system
PL2547553T3 (pl)	2017-09-29	Zacisk
GB2477036B (en)	2015-08-19	A connector
AU330042S (en)	2010-03-24	A telephone
GB2504558B8 (en)	2016-08-03	A delivery aid
ZA201003255B (en)	2011-02-23	A knockdown connecting system
AU2010905309A0 (en)	2010-12-16	A Donation System
ZA201104825B (en)	2012-06-27	A fluid delivery system
AU2010905468A0 (en)	2011-01-06	A pump arrangement
GB201118328D0 (en)	2011-12-07	A communication system